Institutional Ownership Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN). We have compiled data on the 626 institutions that hold shares in the stock, with a total of 183 Million shares, which have been reported (via 13F filing form) to have a value of $12.5 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
22,738,349
shares
|
$1.55 Billion
0.04% of portfolio
|
Q2 2024
Added 57.05%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
19,372,185
shares
|
$1.32 Billion
0.02% of portfolio
|
Q4 2024
Added 0.49%
|
|
Primecap Management CO
Pasadena, CA |
Feb 10, 2025 Q4 2024 |
18,189,171
shares
|
$1.24 Billion
0.94% of portfolio
|
Q4 2024
Reduced 3.59%
|
|
Dodge & Cox
San Francisco, CA |
Feb 13, 2025 Q4 2024 |
14,746,235
shares
|
$1.01 Billion
0.61% of portfolio
|
Q4 2024
Added 6.1%
|
|
Capital Research Global Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
12,991,772
shares
|
$887 Million
0.18% of portfolio
|
Q4 2024
Added 23.79%
|
|
Viking Global Investors LP
|
Feb 14, 2025 Q4 2024 |
10,510,550
shares
|
$717 Million
2.34% of portfolio
|
Q4 2024
Added 7.76%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
9,112,275
shares
|
$622 Million
0.02% of portfolio
|
Q4 2024
Added 3.28%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Feb 14, 2025 Q4 2024 |
4,500,248
shares
|
$307 Million
0.08% of portfolio
|
Q4 2024
Added 5.11%
|
|
Norges Bank
Oslo, Q8 |
Feb 12, 2025 Q4 2024 |
3,569,831
shares
|
$244 Million
0.03% of portfolio
|
Q4 2024
New holding
|
|
Paul Singer
Elliott Investment Management L.P. | West Palm Beach, Fl
|
Feb 14, 2025 Q4 2024 |
3,500,338
shares
|
$239 Million
1.41% of portfolio
|
Q1 2024
Added 16.66%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
3,288,778
shares
|
$224 Million
0.02% of portfolio
|
Q4 2024
Added 0.88%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,063,810
shares
|
$141 Million
0.21% of portfolio
|
Q2 2023
Added 0.45%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,725,039
shares
|
$118 Million
0.02% of portfolio
|
Q4 2024
Added 16.21%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
1,669,518
shares
|
$114 Million
0.04% of portfolio
|
Q4 2024
Added 7.98%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
1,545,656
shares
|
$105 Million
0.01% of portfolio
|
Q4 2024
Reduced 45.03%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
1,508,633
shares
|
$103 Million
0.02% of portfolio
|
Q4 2024
Added 75.02%
|
|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,462,500
shares
|
$99.8 Million
1.4% of portfolio
|
Q4 2024
Reduced 28.24%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,423,508
shares
|
$97.2 Million
0.02% of portfolio
|
Q4 2024
Added 1.56%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,340,432
shares
|
$91.5 Million
0.01% of portfolio
|
Q4 2024
Added 54.03%
|
|
Aqr Capital Management LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
1,283,599
shares
|
$87.6 Million
0.11% of portfolio
|
Q4 2024
Added 114.47%
|
|
Manning & Napier Group, LLC
|
Apr 15, 2024 Q1 2024 |
1,153,785
shares
|
$78.7 Million
1.15% of portfolio
|
Q1 2024
Added 0.76%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
1,152,913
shares
|
$78.7 Million
0.02% of portfolio
|
Q4 2024
Reduced 13.94%
|
|
Palo Alto Investors LP
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
1,067,266
shares
|
$72.8 Million
11.21% of portfolio
|
Q4 2024
Reduced 2.09%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,055,087
shares
|
$72 Million
0.02% of portfolio
|
Q4 2024
Added 19.83%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,006,922
shares
|
$68.7 Million
0.02% of portfolio
|
Q4 2024
Reduced 17.66%
|